Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/14368
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Prachayasittikul S. | |
dc.contributor.author | Worachartcheewan A. | |
dc.contributor.author | Pingaew R. | |
dc.contributor.author | Suksrichavalit T. | |
dc.contributor.author | Isarankura-Na-Ayudhya C. | |
dc.contributor.author | Ruchirawat S. | |
dc.contributor.author | Prachayasittikul V. | |
dc.date.accessioned | 2021-04-05T03:34:25Z | - |
dc.date.available | 2021-04-05T03:34:25Z | - |
dc.date.issued | 2012 | |
dc.identifier.issn | 15701808 | |
dc.identifier.other | 2-s2.0-84858217824 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/14368 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84858217824&doi=10.2174%2f157018012799129918&partnerID=40&md5=ec25daa363a28ab424400767a86ceb54 | |
dc.description.abstract | 5-Substituted uracils were reported to be important core structure of diverse therapeutics. Herein, novel mixed ligand transition metal (Mn, Cu, Ni) complexes of 5-iodouracil (5Iu) with 8-hydroxyquinoline or 8HQ (1-3) and 5-nitrouracil (5Nu) with 8HQ (4-6) have been synthesized. The metal complexes 1-6 exert significant cytotoxicity against HepG2, A-549, HuCCA-1 and MOLT-3 cell lines. Particularly, the cytotoxicities of tested complexes against HepG2 cells show their IC 50 values lower than the reference drug. Cu complex of 5Nu (5Nu-Cu-8HQ, 5) is the most potent and promising cytotoxic compound. Mn complex of 5Iu (5Iu-Mn-8HQ, 1) is shown to be the most potent antioxidant. This finding reveals the application of using simple and commercially available bioactive ligands like 5Iu, 5Nu and 8HQ for the design and construction of new lead compounds with significant and promising bioactivities. © 2012 Bentham Science Publishers. | |
dc.subject | 5 iodouracil 8 hydroxyquinoline copper complex | |
dc.subject | 5 iodouracil 8 hydroxyquinoline manganese complex | |
dc.subject | 5 iodouracil 8 hydroxyquinoline nickel complex | |
dc.subject | 5 nitrouracil 8 hydroxyquinoline copper complex | |
dc.subject | 5 nitrouracil 8 hydroxyquinoline manganese complex | |
dc.subject | 5 nitrouracil 8 hydroxyquinoline nickel complex | |
dc.subject | 8 quinolinol derivative | |
dc.subject | copper complex | |
dc.subject | doxorubicin | |
dc.subject | etoposide | |
dc.subject | fialuridine | |
dc.subject | manganese derivative | |
dc.subject | metal complex | |
dc.subject | nickel complex | |
dc.subject | scavenger | |
dc.subject | superoxide | |
dc.subject | superoxide dismutase | |
dc.subject | unclassified drug | |
dc.subject | uracil derivative | |
dc.subject | acute lymphoblastic leukemia | |
dc.subject | antioxidant activity | |
dc.subject | article | |
dc.subject | bile duct carcinoma | |
dc.subject | cancer cell culture | |
dc.subject | cell strain HepG2 | |
dc.subject | controlled study | |
dc.subject | cytotoxicity | |
dc.subject | drug potency | |
dc.subject | drug structure | |
dc.subject | drug synthesis | |
dc.subject | human | |
dc.subject | human tissue | |
dc.subject | lung carcinoma | |
dc.subject | priority journal | |
dc.title | Metal complexes of uracil derivatives with cytotoxicity and superoxide scavenging activity | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Letters in Drug Design and Discovery. Vol 9, No.3 (2012), p.282-287 | |
dc.identifier.doi | 10.2174/157018012799129918 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.